Microneedle: Recent Advancements In Transdermal Drug Delivery System

被引:1
作者
Patel, Bhavya [1 ]
Parekh, Foram [1 ]
Vyas, Krupa [1 ]
Patani, Pragnesh [1 ]
机构
[1] Khyati Coll Pharm, Ahmadabad, Gujarat, India
关键词
Transdermal Drug Delivery System; Microneedles; Recent Advancement; Microneedle patches; skin permeability; DISSOLVING MICRONEEDLES; HYALURONIC-ACID; ARRAYS; ELECTROPORATION; FORMULATIONS; PENETRATION; INSULIN; PATCHES; CANCER; SAFETY;
D O I
10.47750/pnr.2022.13.S08.258
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Due to its reduced invasiveness, low rejection rate, and remarkable ease of administration, transdermal drug delivery (TDD) has recently become a viable alternative to oral and injectable administration. The transdermal medication delivery method is a treatment strategy that is extraordinarily safe and well-tolerated and has enormous potential for delivering active ingredients against a variety of illnesses. However, because to the low skin permeability of the majority of active medicines in the formulation, its application is currently restricted in clinical settings. To get over this restriction, new strategies for skin permeation improvement techniques are offered. The drug delivery industry has undergone a revolution due to recent advances at the nano and microscale. A growing trend in drug delivery applications is the use of several kinds of microneedles (MNs), in particular because they are safe, compliant with patient preferences, and practical. Microneedles are a distinct, cutting-edge, and successful method created to administer medicinal chemicals and immunological components in a number of disorders. With appropriate examples and recent developments, various MN types-solid, hollow, coated, dissolving, and hydrogel forming-are described. We summarize recent developments in microneedles for therapeutic uses in this review.
引用
收藏
页码:2078 / 2086
页数:9
相关论文
共 50 条
[1]   Transdermal delivery of antidiabetic drugs: formulation and delivery strategies [J].
Ahad, Abdul ;
Al-Saleh, Abdulmohsen A. ;
Akhtar, Naseem ;
Al-Mohizea, Abdullah M. ;
Al-Jenoobi, Fahad I. .
DRUG DISCOVERY TODAY, 2015, 20 (10) :1217-1227
[2]  
Ali S., 2015, Res. J. Pharm. Technol, V8, P103, DOI DOI 10.5958/0974-360X.2015.00019.0
[3]   Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum [J].
Alkilani, Ahlam Zaid ;
McCrudden, Maeliosa T. C. ;
Donnelly, Ryan F. .
PHARMACEUTICS, 2015, 7 (04) :438-470
[4]  
[Anonymous], 2019, HUM GENE THER, V30, P5
[5]   An overview of clinical and commercial impact of drug delivery systems [J].
Anselmo, Aaron C. ;
Mitragotri, Samir .
JOURNAL OF CONTROLLED RELEASE, 2014, 190 :15-28
[6]   Transdermal drug delivery in pain management [J].
Bajaj, Sanjay ;
Whiteman, Abigail ;
Brandner, Brigitta .
BJA EDUCATION, 2011, 11 (02) :39-43
[7]   In vivo assessment of safety of microneedle arrays in human skin [J].
Bal, Suzanne M. ;
Caussin, Julia ;
Pavel, Stan ;
Bouwstra, Joke A. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 35 (03) :193-202
[8]   Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments [J].
Balistreri, C. R. ;
Candore, G. ;
Lio, D. ;
Carruba, G. .
CANCER GENE THERAPY, 2014, 21 (01) :2-11
[9]  
Banga AK, 2009, EXPERT OPIN DRUG DEL, V6, P343, DOI [10.1517/17425240902841935, 10.1517/17425240902841935 ]
[10]   Penetration of metallic nanoparticles in human full-thickness skin [J].
Baroli, Biancamaria ;
Ennas, Maria Grazia ;
Loffredo, Felice ;
Isola, Michela ;
Pinna, Raimondo ;
Arturo Lopez-Quintela, M. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) :1701-1712